For: | Luan D, Zhao MG, Shi YC, Li L, Cao YJ, Feng HX, Zhang ZJ. Mechanisms of repetitive transcranial magnetic stimulation for anti-depression: Evidence from preclinical studies. World J Psychiatr 2020; 10(10): 223-233 [PMID: 33134113 DOI: 10.5498/wjp.v10.i10.223] |
---|---|
URL: | https://www.wjgnet.com/2220-3206/full/v10/i10/223.htm |
Number | Citing Articles |
1 |
Paul B Fitzgerald, Shane Gill, Michael Breakspear, Jayashri Kulkarni, Leo Chen, Saxby Pridmore, Subramanian Purushothaman, Cherrie Galletly, Patrick Clarke, Felicity Ng, Salam Hussain, Suneel Chamoli, Tibi Csizmadia, Patrick Tolan, Luca Cocchi, Samir Ibrahim OAM, Kavitha Shankar, Shanthi Sarma, Michael Lau, Colleen Loo, Tarun Yadav, Kate E Hoy. Revisiting the effectiveness of repetitive transcranial magnetic stimulation treatment in depression, again. Australian & New Zealand Journal of Psychiatry 2022; 56(8): 905 doi: 10.1177/00048674211068788
|
2 |
Ramey G. Monem, Olaoluwa O. Okusaga. Repetitive Transcranial Magnetic Stimulation: A Potential Treatment for Obesity in Patients with Schizophrenia. Behavioral Sciences 2021; 11(6): 86 doi: 10.3390/bs11060086
|
3 |
You Xu, Li Han, Youdan Wei, Hongjing Mao, Zhenghe Yu. Combined repetitive transcranial magnetic stimulation and medication treatment for depression is associated with serum amyloid a level: Evidence from naturalistic clinical practice. Frontiers in Neuroscience 2022; 16 doi: 10.3389/fnins.2022.1002816
|
4 |
Guo-Rong Wu, Chris Baeken. Exploring potential working mechanisms of accelerated HF-rTMS in refractory major depression with a focus on locus coeruleus connectivity. European Psychiatry 2024; 67(1) doi: 10.1192/j.eurpsy.2024.1769
|
5 |
AmirMohammad Sharafi, Sina Pakkhesal, Ali Fakhari, Nazli Khajehnasiri, Ali Ahmadalipour. Rapid treatments for depression: Endocannabinoid system as a therapeutic target. Neuroscience & Biobehavioral Reviews 2022; 137: 104635 doi: 10.1016/j.neubiorev.2022.104635
|
6 |
Paul B Fitzgerald, Saxby Pridmore. Letter to the Editor regarding ‘Five facts about rTMS?’. Australian & New Zealand Journal of Psychiatry 2023; 57(2): 303 doi: 10.1177/00048674221121740
|
7 |
Di Luan, Dongfang You, Yaqian Wu, Fangfang Wu, Zhi Xu, Ling Li, Jiao Jiao, Aini Zhang, Haixia Feng, Yan Kong, Yang Zhao, Zhijun Zhang. Effects of interaction between single nucleotide polymorphisms and psychosocial factors on the response to antidepressant treatment in patients with major depressive disorder. Journal of Genetics and Genomics 2022; 49(6): 587 doi: 10.1016/j.jgg.2021.11.012
|
8 |
Claudete da Costa-Oliveira, Michele Lafayette Pereira, Nicole Ferrari de Carvalho, Luiza Aparecida Luna Silvério, Ygor Jessé Ramos, Priscila Gava Mazzola. Exploring the Significance of Pharmaceutical Care in Mental Health: A Spotlight on Cannabis. Pharmacy 2024; 12(4): 100 doi: 10.3390/pharmacy12040100
|
9 |
Brânduşa Vornicu. Transcranial magnetic stimulation (TMS) – part I. Psihiatru.ro 2021; 3(66): 30 doi: 10.26416/Psih.65.2.2021.5374
|
10 |
Naoki Kurimoto, Takahiko Inagaki, Takashi Aoki, Hiroshi Kadotani, Fujiki Kurimoto, Kenichi Kuriyama, Naoto Yamada, Yuji Ozeki. Factors causing a relapse of major depressive disorders following successful electroconvulsive therapy: A retrospective cohort study. World Journal of Psychiatry 2021; 11(10): 841-853 doi: 10.5498/wjp.v11.i10.841
|
11 |
Chongyun Wu, Luoman Yang, Shu Feng, Ling Zhu, Luodan Yang, Timon Cheng-Yi Liu, Rui Duan. Therapeutic non-invasive brain treatments in Alzheimer’s disease: recent advances and challenges. Inflammation and Regeneration 2022; 42(1) doi: 10.1186/s41232-022-00216-8
|